Literature DB >> 24756883

Discordant patterns of tissue-specific genetic characteristics in the HIV-1 env gene from HIV-associated neurocognitive disorder (HAND) and non-HAND patients.

Yabo Ouyang1, Lifeng Liu, Yulin Zhang, Lin Yuan, Zhiying Liu, Sufang Yang, Feili Wei, Luxin Qiao, Dexi Chen.   

Abstract

The genetic evolution of HIV-1 in the central nervous system (CNS) is different from that in peripheral tissues. We analyzed 121 clonal sequences of the V3-V5 regions of the env gene generated from paired cerebrospinal fluid (CSF) and plasma samples from nine chronically infected patients (four with HIV-associated neurocognitive disorder (HAND) and five without HAND). The sequence analysis indicated the significant differences between CSF and plasma was only observed in the C4 region (P = 0.043) in HAND patients. Significant increases in synonymous substitutions (dS) within the V4 region (P = 0.020) and in nonsynonymous substitutions (dN) within the C4 region (P = 0.029) were observed in the CSF-derived sequences. By contrast, CSF-derived sequences from non-HAND patients showed similar levels of diversity; dS and dN as the plasma-derived sequences. Signature differences between the CSF- and plasma-derived sequences were found at 12 amino acid positions for HAND patients and nine positions for non-HAND patients. Interestingly, five sites (positions 388, 396, 397, 404, and 406) that all belong to signature patterns exhibited positive selection pressure in CSF samples, but only site 406 was positively selected in the plasma samples from the HAND patients. Conversely, in the non-HAND patients, there were four sites (positions 397, 404, 432, and 446) showed positive selection pressure in the plasma samples, but only site 446 in the CSF samples. These results suggest that discordant patterns of genetic evolution occur between the tissue-specific HIV-1 quasispecies in the HAND and non-HAND patients. Viral molecular heterogeneity between specific tissues is greater in patients with HAND compared to non-HAND patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24756883     DOI: 10.1007/s13365-014-0247-5

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  40 in total

Review 1.  Drug delivery to the central nervous system: a review.

Authors:  Ambikanandan Misra; S Ganesh; Aliasgar Shahiwala; Shrenik P Shah
Journal:  J Pharm Pharm Sci       Date:  2003 May-Aug       Impact factor: 2.327

2.  Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment.

Authors:  George K Hightower; Joseph K Wong; Scott L Letendre; Anya A Umlauf; Ronald J Ellis; Caroline C Ignacio; Robert K Heaton; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; J A McCutchan; Igor Grant; Susan J Little; Douglas D Richman; Sergei L Kosakovsky Pond; Davey M Smith
Journal:  Virology       Date:  2012-09-20       Impact factor: 3.616

3.  An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China.

Authors:  Yulin Zhang; Luxin Qiao; Wei Ding; Feili Wei; Qingxia Zhao; Xicheng Wang; Ying Shi; Ning Li; Davey Smith; Dexi Chen
Journal:  J Neurovirol       Date:  2012-03-13       Impact factor: 2.643

4.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

5.  The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Authors:  Ned C Sacktor; Matthew Wong; Noeline Nakasujja; Richard L Skolasky; Ola A Selnes; Seggane Musisi; Kevin Robertson; Justin C McArthur; Allan Ronald; Elly Katabira
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

6.  Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection.

Authors:  Rong Rong; Frederic Bibollet-Ruche; Joseph Mulenga; Susan Allen; Jerry L Blackwell; Cynthia A Derdeyn
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

Authors:  Christopher N Scanlan; Ralph Pantophlet; Mark R Wormald; Erica Ollmann Saphire; Robyn Stanfield; Ian A Wilson; Hermann Katinger; Raymond A Dwek; Pauline M Rudd; Dennis R Burton
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  HIV dementia patients exhibit reduced viral neutralization and increased envelope sequence diversity in blood and brain.

Authors:  Guido Van Marle; Sean B Rourke; Kunyan Zhang; Claudia Silva; Julie Ethier; M John Gill; Christopher Power
Journal:  AIDS       Date:  2002-09-27       Impact factor: 4.177

9.  The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.

Authors:  Fiorella Rossi; Bianca Querido; Manideepthi Nimmagadda; Simon Cocklin; Sonia Navas-Martín; Julio Martín-García
Journal:  Retrovirology       Date:  2008-10-06       Impact factor: 4.602

10.  HIV-1 envelope glycoprotein resistance to monoclonal antibody 2G12 is subject-specific and context-dependent in macaques and humans.

Authors:  Delphine C Malherbe; Rogier W Sanders; Marit J van Gils; Byung Park; Michelle M Gomes; Hanneke Schuitemaker; Susan Barnett; Nancy L Haigwood
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more
  8 in total

Review 1.  HIV-1 target cells in the CNS.

Authors:  Sarah B Joseph; Kathryn T Arrildt; Christa B Sturdevant; Ronald Swanstrom
Journal:  J Neurovirol       Date:  2014-09-19       Impact factor: 2.643

2.  Transcriptome analyses identify key cellular factors associated with HIV-1-associated neuropathogenesis in infected men.

Authors:  Narasimhan J Venkatachari; Siddhartha Jain; Leah Walker; Shalmali Bivalkar-Mehla; Ansuman Chattopadhyay; Ziv Bar-Joseph; Charles Rinaldo; Ann Ragin; Eric Seaberg; Andrew Levine; James Becker; Eileen Martin; Ned Sacktor; Velpandi Ayyavoo
Journal:  AIDS       Date:  2017-03-13       Impact factor: 4.177

3.  Mitochondrial DNA D-loop AG/TC transition mutation in cortical neurons of mice after long-term exposure to nucleoside analogues.

Authors:  Yulin Zhang; Bishi Wang; Qi Liang; Luxin Qiao; Bin Xu; Hongwei Zhang; Sufang Yang; Jun Chen; Hongliang Guo; Jian Wu; Dexi Chen
Journal:  J Neurovirol       Date:  2015-05-27       Impact factor: 2.643

4.  Envelope gene evolution and HIV-1 neuropathogenesis.

Authors:  Fabián J Vázquez-Santiago; Vanessa Rivera-Amill
Journal:  J Neuroinfect Dis       Date:  2015-08-20

5.  Phenotypic Correlates of HIV-1 Macrophage Tropism.

Authors:  Kathryn T Arrildt; Celia C LaBranche; Sarah B Joseph; Elena N Dukhovlinova; William D Graham; Li-Hua Ping; Gretja Schnell; Christa B Sturdevant; Laura P Kincer; Macpherson Mallewa; Robert S Heyderman; Annelies Van Rie; Myron S Cohen; Serena Spudich; Richard W Price; David C Montefiori; Ronald Swanstrom
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

Review 6.  Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders.

Authors:  Teresa H Evering
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

7.  Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.

Authors:  Teresa H Evering; Edwin Kamau; Leslie St Bernard; Charles B Farmer; Xiang-Peng Kong; Martin Markowitz
Journal:  Retrovirology       Date:  2014-08-15       Impact factor: 4.602

8.  Application of Data Mining Algorithms for Dementia in People with HIV/AIDS.

Authors:  Luana Ibiapina Cordeiro Calíope Pinheiro; Maria Lúcia Duarte Pereira; Marcial Porto Fernandez; Francisco Mardônio Vieira Filho; Wilson Jorge Correia Pinto de Abreu; Pedro Gabriel Calíope Dantas Pinheiro
Journal:  Comput Math Methods Med       Date:  2021-07-09       Impact factor: 2.238

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.